MONOPAR THERAPEUTICS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.8949 USD | +9.80% |
|
+11.17% | +163.05% |
| 24/05 | Monopar Therapeutics Names Karthik Radhakrishnan as CFO | MT |
| 24/05 | Monopar Therapeutics Inc. Announces CFO Changes | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MONOPAR THERAPEUTICS INC. | Other Biotechnology & Medical Research | +9.80% | +11.17% | +163.05% | -0.57% | - | 1.42Cr |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- MNPR Stock
- Charts Monopar Therapeutics Inc.
- Comparison Chart
